Replies to post #347007 on NorthWest Biotherapeutics Inc (NWBO)

[spartex]

Even Ken Frazier acknowledged that there could be a possible bidding war for an asset like the DCVax cancer vaccine platform

ATLnsider, Ken Frazier didn't mention an asset "like the DCVax cancer vaccine platform" but I believe you were using this as an example of what he might acknowledge would be a technology that might cause a bidding war.

That said, NWBO is way below the value of what he said: ""Right now, biotech’s at an all-time high," Frazier said."

NWBO needs TLD news and partnerships/approvals to boost its market cap (price) into much higher B's before NWBO management would even entertain any kind of offers. I believe it was $20 B that some poster heard LP say some years back at a side bar during ASCO or other conference.

Thanks for your other insights!